A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F. Chemaly, Michael Boeckh, Sudhakar Pipavath et al.|Clinical Infectious Diseases|2019Cited by 75
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-LearningElizabeth F. Krakow, Erica E. M. Moodie, Michael Hemmer et al.|American Journal of Epidemiology|2017Cited by 42
Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatmentElizabeth F. Krakow, Jean‐Sébastien Delisle, Julie Bergeron et al.|Blood Reviews|2014Cited by 18